ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 180 filers reported holding ARIAD PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.88 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $981,000 | -44.5% | 78,804 | -38.9% | 0.00% | -50.0% |
| Q3 2016 | $1,766,000 | +83.0% | 128,964 | -1.3% | 0.00% | +100.0% |
| Q2 2016 | $965,000 | +15.4% | 130,696 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $836,000 | -7.5% | 130,696 | -9.7% | 0.00% | 0.0% |
| Q4 2015 | $904,000 | +9.0% | 144,674 | +2.0% | 0.00% | 0.0% |
| Q3 2015 | $829,000 | -8.4% | 141,874 | +29.6% | 0.00% | 0.0% |
| Q2 2015 | $905,000 | +10.5% | 109,494 | +10.2% | 0.00% | 0.0% |
| Q1 2015 | $819,000 | +24.1% | 99,394 | +3.5% | 0.00% | 0.0% |
| Q4 2014 | $660,000 | +27.4% | 95,994 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $518,000 | +3.6% | 95,994 | +22.3% | 0.00% | 0.0% |
| Q2 2014 | $500,000 | -33.4% | 78,494 | -15.7% | 0.00% | 0.0% |
| Q1 2014 | $751,000 | +23.5% | 93,154 | +4.5% | 0.00% | 0.0% |
| Q4 2013 | $608,000 | -98.0% | 89,154 | -94.5% | 0.00% | -97.3% |
| Q3 2013 | $29,938,000 | +30.6% | 1,627,038 | +24.1% | 0.04% | +23.3% |
| Q2 2013 | $22,924,000 | – | 1,310,737 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $69,390,000 | 26.80% |
| Opaleye Management Inc. | 1,500,000 | $8,100,000,000 | 6.31% |
| Camber Capital Management LP | 6,000,000 | $32,400,000 | 3.04% |
| Ghost Tree Capital, LLC | 700,000 | $3,780,000 | 2.05% |
| Granite Point Capital Management, L.P. | 700,000 | $3,780,000 | 1.88% |
| Duquesne Family Office | 1,645,000 | $8,883,000 | 1.09% |
| Geduld E E | 272,200 | $1,470,000 | 1.04% |
| Elk Creek Partners, LLC | 659,232 | $3,560,000 | 0.93% |
| Palo Alto Investors LP | 2,231,717 | $12,051,000 | 0.90% |
| HighVista Strategies LLC | 1,200,000 | $6,480,000 | 0.87% |